|
1
|
Song HY, Dunbar JD, Zhang YX, Guo D and
Donner DB: Identification of a protein with homology to hsp90 that
binds the type 1 tumor necrosis factor receptor. J Biol Chem.
270:3574–3581. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen CF, Chen Y, Dai K, Chen PL, Riley DJ
and Lee WH: A new member of the hsp90 family of molecular
chaperones interacts with the retinoblastoma protein during mitosis
and after heat shock. Mol Cell Biol. 16:4691–4699. 1996.PubMed/NCBI
|
|
3
|
Matassa DS, Amoroso MR, Maddalena F,
Landriscina M and Esposito F: New insights into TRAP1 pathway. Am J
Cancer Res. 2:235–248. 2012.PubMed/NCBI
|
|
4
|
Chen B, Piel WH, Gui L, Bruford E and
Monteiro A: The HSP90 family of genes in the human genome: insights
into their divergence and evolution. Genomics. 86:627–637. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Felts SJ, Owen BA, Nguyen P, Trepel J,
Donner DB and Toft DO: The hsp90-related protein TRAP1 is a
mitochondrial protein with distinct functional properties. J Biol
Chem. 275:3305–3312. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cechetto JD and Gupta RS: Immunoelectron
microscopy provides evidence that tumor necrosis factor
receptor-associated protein 1 (TRAP-1) is a mitochondrial protein
which also localizes at specific extramitochondrial sites. Exp Cell
Res. 260:30–39. 2000. View Article : Google Scholar
|
|
7
|
Kang BH, Plescia J, Dohi T, Rosa J, Doxsey
SJ and Altieri DC: Regulation of tumor cell mitochondrial
homeostasis by an organelle-specific Hsp90 chaperone network. Cell.
131:257–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Costantino E, Maddalena F, Calise S,
Piscazzi A, Tirino V, Fersini A, Ambrosi A, Neri V, Esposito F and
Landriscina M: TRAP1, a novel mitochondrial chaperone responsible
for multi-drug resistance and protection from apoptotis in human
colorectal carcinoma cells. Cancer Lett. 279:39–46. 2009.
View Article : Google Scholar
|
|
9
|
Montesano Gesualdi N, Chirico G, Pirozzi
G, Costantino E, Landriscina M and Esposito F: Tumor necrosis
factor-associated protein 1 (TRAP-1) protects cells from oxidative
stress and apoptosis. Stress. 10:342–350. 2007.PubMed/NCBI
|
|
10
|
Landriscina M, Laudiero G, Maddalena F,
Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A,
Pucci P and Esposito F: Mitochondrial chaperone Trap1 and the
calcium binding protein Sorcin interact and protect cells against
apoptosis induced by antiblastic agents. Cancer Res. 70:6577–6586.
2010. View Article : Google Scholar
|
|
11
|
Ghosh JC, Siegelin MD, Dohi T and Altieri
DC: Heat shock protein 60 regulation of the mitochondrial
permeability transition pore in tumor cells. Cancer Res.
70:8988–8993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasola A, Sciacovelli M, Pantic B and
Bernardi P: Signal transduction to the permeability transition
pore. FEBS Lett. 584:1989–1996. 2010. View Article : Google Scholar
|
|
13
|
Altieri DC: Hsp90 regulation of
mitochondrial protein folding: from organelle integrity to cellular
homeostasis. Cell Mol Life Sci. 70:2463–2472. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Pang E, Loo RR, Rao J, Go VL, Loo
JA and Lu QY: Concomitant inhibition of HSP90, its mitochondrial
localized homologue TRAP1 and HSP27 by green tea in pancreatic
cancer HPAF-II cells. Proteomics. 11:4638–4647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao JY, Song BR, Peng JJ and Lu YM:
Correlation between mitochondrial TRAP-1 expression and lymph node
metastasis in colorectal cancer. World J Gastroenterol.
18:5965–5971. 2012. View Article : Google Scholar
|
|
16
|
Han JJ, Baek SK, Lee JJ, Kim GY, Kim SY
and Lee SH: Combination of TRAP1 and ERCC1 expression predicts
clinical outcomes in metastatic colorectal cancer treated with
oxaliplatin/5-fluorouracil. Cancer Res Treat. 46:55–64. 2014.
View Article : Google Scholar
|
|
17
|
Zhan Q, Tsai S, Lu Y, Wang C, Kwan Y and
Ngai S: RuvBL2 is involved in histone deacetylase inhibitor
PCI-24781-induced cell death in SK-N-DZ neuroblastoma cells. PLoS
One. 8:e716632013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Megger DA, Bracht T, Kohl M, Ahrens M,
Naboulsi W, Weber F, Hoffmann AC, Stephan C, Kuhlmann K, Eisenacher
M, Schlaak JF, Baba HA, Meyer HE and Sitek B: Proteomic differences
between hepatocellular carcinoma and nontumorous liver tissue
investigated by a combined gel-based and label-free quantitative
proteomics study. Mol Cell Proteomics. 12:2006–2020. 2013.
View Article : Google Scholar
|
|
19
|
Im CN and Seo JS: Overexpression of tumor
necrosis factor receptor-associated protein 1 (TRAP1), leads to
mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB
Rep. Dec 1–2013.(Epub ahead of print). pii: 2469.
|
|
20
|
Agorreta J, Hu J, Liu D, Delia D, Turley
H, Ferguson DJ, Iborra F, Pajares MJ, Larrayoz M, Zudaire I, Pio R,
Montuenga LM, Harris AL, Gatter K and Pezzella F: TRAP1 regulates
proliferation, mitochondrial function and has prognostic
significance in NSCLC. Mol Cancer Res. 3–June;2014.(Epub ahead of
print).
|
|
21
|
Chae YC, Angelin A, Lisanti S, Kossenkov
AV, Speicher KD, Wang H, Powers JF, Tischler AS, Pacak K, Fliedner
S, Michalek RD, Karoly ED, Wallace DC, Languino LR, Speicher DW and
Altieri DC: Landscape of the mitochondrial Hsp90 metabolome in
tumours. Nat Commun. 4:21392013.PubMed/NCBI
|
|
22
|
Sciacovelli M, Guzzo G, Morello V, Frezza
C, Zheng L, Nannini N, Calabrese F, Laudiero G, Esposito F,
Landriscina M, Defilippi P, Bernardi P and Rasola A: The
mitochondrial chaperone TRAP1 promotes neoplastic growth by
inhibiting succinate dehydrogenase. Cell Metab. 17:988–999. 2013.
View Article : Google Scholar
|
|
23
|
Yoshida S, Tsutsumi S, Muhlebach G,
Sourbier C, Lee MJ, Lee S, Vartholomaiou E, Tatokoro M, Beebe K,
Miyajima N, Mohney RP, Chen Y, Hasumi H, Xu W, Fukushima H,
Nakamura K, Koga F, Kihara K, Trepel J, Picard D and Neckers L:
Molecular chaperone TRAP1 regulates a metabolic switch between
mitochondrial respiration and aerobic glycolysis. Proc Natl Acad
Sci USA. 110:E1604–E1612. 2013. View Article : Google Scholar
|
|
24
|
Aust S, Bachmayr-Heyda A, Pateisky P, Tong
D, Darb-Esfahani S, Denkert C, Chekerov R, Sehouli J, Mahner S, Van
Gorp T, Vergote I, Speiser P, Horvat R, Zeillinger R and Pils D:
Role of TRAP1 and estrogen receptor alpha in patients with ovarian
cancer - a study of the OVCAD consortium. Mol Cancer. 11:692012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Walker G, MacLeod K, Williams AR, Cameron
DA, Smyth JF and Langdon SP: Estrogen-regulated gene expression
predicts response to endocrine therapy in patients with ovarian
cancer. Gynecol Oncol. 106:461–468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O’Donnell AJ, Macleod KG, Burns DJ, Smyth
JF and Langdon SP: Estrogen receptor-alpha mediates gene expression
changes and growth response in ovarian cancer cells exposed to
estrogen. Endocr Relat Cancer. 12:851–866. 2005.
|
|
27
|
Amoroso MR, Matassa DS, Laudiero G,
Egorova AV, Polishchuk RS, Maddalena F, Piscazzi A, Paladino S,
Sarnataro D, Garbi C, Landriscina M and Esposito F: TRAP1 and the
proteasome regulatory particle TBP7/Rpt3 interact in the
endoplasmic reticulum and control cellular ubiquitination of
specific mitochondrial proteins. Cell Death Differ. 19:592–604.
2012. View Article : Google Scholar
|
|
28
|
Matassa DS, Amoroso MR, Agliarulo I,
Maddalena F, Sisinni L, Paladino S, Romano S, Romano MF, Sagar V,
Loreni F, Landriscina M and Esposito F: Translational control in
the stress adaptive response of cancer cells: a novel role for the
heat shock protein TRAP1. Cell Death Dis. 4:e8512013. View Article : Google Scholar
|
|
29
|
Wang F, Durfee LA and Huibregtse JM: A
cotranslational ubiquitination pathway for quality control of
misfolded proteins. Mol Cell. 50:368–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brandman O, Stewart-Ornstein J, Wong D,
Larson A, Williams CC, Li GW, Zhou S, King D, Shen PS, Weibezahn J,
Dunn JG, Rouskin S, Inada T, Frost A and Weissman JS: A
ribosome-bound quality control complex triggers degradation of
nascent peptides and signals translation stress. Cell.
151:1042–1054. 2012. View Article : Google Scholar
|
|
31
|
Ruggero D: Translational control in cancer
etiology. Cold Spring Harb Perspect Biol. 5:pii a012336. 2013.
View Article : Google Scholar
|
|
32
|
Silvera D, Formenti SC and Schneider RJ:
Translational control in cancer. Nat Rev Cancer. 10:254–266. 2010.
View Article : Google Scholar
|
|
33
|
Liu B, Han Y and Qian SB: Cotranslational
response to proteotoxic stress by elongation pausing of ribosomes.
Mol Cell. 49:453–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maddalena F, Sisinni L, Lettini G,
Condelli V, Matassa DS, Piscazzi A, Amoroso MR, La Torre G,
Esposito F and Landriscina M: Resistance to paclitxel in breast
carcinoma cells requires a quality control of mitochondrial
antiapoptotic proteins by TRAP1. Mol Oncol. 7:895–906. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sisinni L, Maddalena F, Lettini G,
Condelli V, Matassa DS, Esposito F and Landriscina M: TRAP1 role in
endoplasmic reticulum stress protection favors resistance to
anthracyclins in breast carcinoma cells. Int J Oncol. 44:573–582.
2014.PubMed/NCBI
|
|
36
|
Pridgeon JW, Olzmann JA, Chin LS and Li L:
PINK1 protects against oxidative stress by phosphorylating
mitochondrial chaperone TRAP1. PLoS Biol. 5:e1722007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takamura H, Koyama Y, Matsuzaki S, Yamada
K, Hattori T, Miyata S, Takemoto K, Tohyama M and Katayama T: TRAP1
controls mitochondrial fusion/fission balance through Drp1 and Mff
expression. PLoS One. 7:e519122012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Karsten P, Hamm S, Pogson JH,
Müller-Rischart AK, Exner N, Haass C, Whitworth AJ, Winklhofer KF,
Schulz JB and Voigt A: TRAP1 rescues PINK1 loss-of-function
phenotypes. Hum Mol Genet. 22:2829–2841. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Costa AC, Loh SH and Martins LM:
Drosophila Trap1 protects against mitochondrial dysfunction
in a PINK1/parkin model of Parkinson’s disease. Cell Death Dis.
4:e4672013. View Article : Google Scholar
|
|
40
|
Butler EK, Voigt A, Lutz AK, Toegel JP,
Gerhardt E, Karsten P, Falkenburger B, Reinartz A, Winklhofer KF
and Schulz JB: The mitochondrial chaperone protein TRAP1 mitigates
α-Synuclein toxicity. PLoS Genet. 8:e10024882012.PubMed/NCBI
|
|
41
|
Fismen S, Thiyagarajan D, Seredkina N,
Nielsen H, Jacobsen S, Elung-Jensen T, Kamper AL, Johansen SD,
Mortensen ES and Rekvig OP: Impact of the tumor necrosis factor
receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and
on progression of murine and human lupus nephritis. Am J Pathol.
182:688–700. 2013. View Article : Google Scholar
|
|
42
|
Saisawat P, Kohl S, Hilger AC, Hwang DY,
Yung Gee H, Dworschak GC, Tasic V, Pennimpede T, Natarajan S,
Sperry E, Matassa DS, Stajić N, Bogdanovic R, de Blaauw I, Marcelis
CL, Wijers CH, Bartels E, Schmiedeke E, Schmidt D, Märzheuser S,
Grasshoff-Derr S, Holland-Cunz S, Ludwig M, Nöthen MM, Draaken M,
Brosens E, Heij H, Tibboel D, Herrmann BG, Solomon BD, de Klein A,
van Rooij IA, Esposito F, Reutter HM and Hildebrandt F: Whole-exome
resequencing reveals recessive mutations in TRAP1 in individuals
with CAKUT and VACTERL association. Kidney Int. 85:1310–1317. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Siebel S and Solomon BD: Mitochondrial
factors and VACTERL association-related congenital malformations.
Mol Syndromol. 4:63–73. 2013. View Article : Google Scholar
|
|
44
|
Zhu Y, Zhou H, Zhu Y, Wan X, Zhu J and
Zhang T: Gene expression of Hsp70, Hsp90, and Hsp110 families in
normal and abnormal embryonic development of mouse forelimbs. Drug
Chem Toxicol. 35:432–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu Y, Ren C, Wan X, Zhu Y, Zhu J, Zhou H
and Zhang T: Gene expression of Hsp70, Hsp90 and Hsp110 families in
normal palate and cleft palate during mouse embryogenesis. Toxicol
Ind Health. 29:915–930. 2013. View Article : Google Scholar
|
|
46
|
Lavery LA, Partridge JR, Ramelot TA,
Elnatan D, Kennedy MA and Agard DA: Structural asymmetry in the
closed state of mitochondrial Hsp90 (TRAP1) supports a two-step ATP
hydrolysis mechanism. Mol Cell. 53:330–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dobbelstein M and Moll U: Targeting
tumour-supportive cellular machineries in anticancer drug
development. Nat Rev Drug Discov. 13:179–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
